TY - JOUR
T1 - Dataset used in the economic evaluation trastuzumab-based regimens for HER-2 positive metastatic breast cancer patients in the Taiwanese healthcare setting
AU - Diaby, Vakaramoko
AU - Wang, Ching Yu
AU - Alqhtani, Hussain
AU - van Boemmel-Wegmann, Sascha
AU - Ali, Askal Ayalew
AU - Balkrishnan, Rajesh
AU - Ko, Yu
AU - Palacio, Sofia
AU - de Lima Lopes, Gilberto
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020/4
Y1 - 2020/4
N2 - The present data article aims to describe the input parameters for a Markov model assessing the cost-effectiveness of four treatment sequences for patients with HER-2 positive metastatic breast cancer. The model input parameters include costs for physician visits, drugs, adverse event management, computed tomography (CT) scan, laboratory tests, echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-logistic distribution used for the transition probabilities.
AB - The present data article aims to describe the input parameters for a Markov model assessing the cost-effectiveness of four treatment sequences for patients with HER-2 positive metastatic breast cancer. The model input parameters include costs for physician visits, drugs, adverse event management, computed tomography (CT) scan, laboratory tests, echocardiogram, utilities, disutilities as well as the shape and scale parameters of a log-logistic distribution used for the transition probabilities.
KW - Cost-effectiveness analysis
KW - Markov model
KW - Metastatic breast cancer
KW - Treatment sequence
UR - http://www.scopus.com/inward/record.url?scp=85078854664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078854664&partnerID=8YFLogxK
U2 - 10.1016/j.dib.2020.105194
DO - 10.1016/j.dib.2020.105194
M3 - Article
AN - SCOPUS:85078854664
SN - 2352-3409
VL - 29
JO - Data in Brief
JF - Data in Brief
M1 - 105194
ER -
